174 related articles for article (PubMed ID: 7563081)
1. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity.
Ni F; Zhu Y; Scheraga HA
J Mol Biol; 1995 Oct; 252(5):656-71. PubMed ID: 7563081
[TBL] [Abstract][Full Text] [Related]
2. Structural examination of the influence of phosphorylation on the binding of fibrinopeptide A to bovine thrombin.
Maurer MC; Peng JL; An SS; Trosset JY; Henschen-Edman A; Scheraga HA
Biochemistry; 1998 Apr; 37(17):5888-902. PubMed ID: 9558322
[TBL] [Abstract][Full Text] [Related]
3. Structural resiliency of an EGF-like subdomain bound to its target protein, thrombin.
Hrabal R; Komives EA; Ni F
Protein Sci; 1996 Feb; 5(2):195-203. PubMed ID: 8745396
[TBL] [Abstract][Full Text] [Related]
4. The interaction of thrombin with fibrinogen. A structural basis for its specificity.
Stubbs MT; Oschkinat H; Mayr I; Huber R; Angliker H; Stone SR; Bode W
Eur J Biochem; 1992 May; 206(1):187-95. PubMed ID: 1587268
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of fibrinogen-Aalpha peptide 1-23 (F8Y) bound to bovine thrombin explains why the mutation of Phe-8 to tyrosine strongly inhibits normal cleavage at Arg-16.
Malkowski MG; Martin PD; Lord ST; Edwards BF
Biochem J; 1997 Sep; 326 ( Pt 3)(Pt 3):815-22. PubMed ID: 9307032
[TBL] [Abstract][Full Text] [Related]
6. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
[TBL] [Abstract][Full Text] [Related]
7. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures.
Slon-Usakiewicz JJ; Sivaraman J; Li Y; Cygler M; Konishi Y
Biochemistry; 2000 Mar; 39(9):2384-91. PubMed ID: 10694407
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-bound conformation of a cyclic anticoagulant peptide using transferred nuclear Overhauser effect (NOE), distance geometry, and NOE simulations.
Ning Q; Ripoll DR; Szewczuk Z; Konishi Y; Ni F
Biopolymers; 1994 Sep; 34(9):1125-37. PubMed ID: 7948726
[TBL] [Abstract][Full Text] [Related]
9. Conformational analysis of gamma' peptide (410-427) interactions with thrombin anion binding exosite II.
Sabo TM; Farrell DH; Maurer MC
Biochemistry; 2006 Jun; 45(24):7434-45. PubMed ID: 16768439
[TBL] [Abstract][Full Text] [Related]
10. High-resolution NMR studies of fibrinogen-like peptides in solution: structure of a thrombin-bound peptide corresponding to residues 7-16 of the A alpha chain of human fibrinogen.
Ni F; Meinwald YC; Vásquez M; Scheraga HA
Biochemistry; 1989 Apr; 28(7):3094-105. PubMed ID: 2742827
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional structure of the complex between acyl-coenzyme A binding protein and palmitoyl-coenzyme A.
Kragelund BB; Andersen KV; Madsen JC; Knudsen J; Poulsen FM
J Mol Biol; 1993 Apr; 230(4):1260-77. PubMed ID: 8503960
[TBL] [Abstract][Full Text] [Related]
12. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
[TBL] [Abstract][Full Text] [Related]
14. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
Fang B; Boross PI; Tozser J; Weber IT
J Mol Biol; 2006 Jul; 360(3):654-66. PubMed ID: 16781734
[TBL] [Abstract][Full Text] [Related]
15. The high-resolution structure of the peripheral subunit-binding domain of dihydrolipoamide acetyltransferase from the pyruvate dehydrogenase multienzyme complex of Bacillus stearothermophilus.
Kalia YN; Brocklehurst SM; Hipps DS; Appella E; Sakaguchi K; Perham RN
J Mol Biol; 1993 Mar; 230(1):323-41. PubMed ID: 8450544
[TBL] [Abstract][Full Text] [Related]
16. A synthetic analog of fibrinogen alpha 27-50 is an inhibitor of thrombin.
Binnie CG; Lord ST
Thromb Haemost; 1991 Feb; 65(2):165-8. PubMed ID: 2053103
[TBL] [Abstract][Full Text] [Related]
17. Stability of protein-bound conformations of bioactive peptides: the folded conformation of an epidermal growth factor-like thrombomodulin fragment is similar to that recognized by thrombin.
Song J; Xu P; Koutychenko A; Ni F
Biopolymers; 2002 Dec; 65(6):373-86. PubMed ID: 12434426
[TBL] [Abstract][Full Text] [Related]
18. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp).
Brennan SO; Hammonds B; George PM
J Clin Invest; 1995 Dec; 96(6):2854-8. PubMed ID: 8675656
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.
Profumo A; Turci M; Damonte G; Ferri F; Magatti D; Cardinali B; Cuniberti C; Rocco M
Biochemistry; 2003 Oct; 42(42):12335-48. PubMed ID: 14567695
[TBL] [Abstract][Full Text] [Related]
20. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
Martin PD; Malkowski MG; DiMaio J; Konishi Y; Ni F; Edwards BF
Biochemistry; 1996 Oct; 35(40):13030-9. PubMed ID: 8855938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
